Comerica Bank
FDMT icon

Comerica Bank’s 4D Molecular Therapeutics FDMT Stock Holding History

Comerica Bank’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$263 Hold
35
– – ﹤0.01% 3663
2025
Q3 		$304 Hold
35
– – ﹤0.01% 3658
2025
Q2 		$130 Hold
35
– – ﹤0.01% 3661
2025
Q1 		$113 Sell
35
-42
-55% -$198 ﹤0.01% 3659
2024
Q4 		$429 Buy
+77
New +$604 ﹤0.01% 3616

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Comerica Bank's FDMT Position: Q4 2025 in Review

Comerica Bank held its 4D Molecular Therapeutics (FDMT) position steady in Q4 2025 at 35 shares worth $263. The position accounts for ﹤0.01% of the portfolio, ranked #3663.

Comerica Bank first reported a position in FDMT in Q4 2024 and has held it in 5 quarters since. The position peaked at $429 in Q4 2024. 153 funds tracked by Wall St. Rank hold FDMT as of Q4 2025.

  • Comerica Bank held 35 shares of 4D Molecular Therapeutics worth $263 as of Q4 2025.
  • Comerica Bank left its 4D Molecular Therapeutics share count unchanged in Q4 2025.
  • 4D Molecular Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3663 holding.
  • Comerica Bank first reported a position in 4D Molecular Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Comerica Bank's 4D Molecular Therapeutics position peaked at $429 in Q4 2024.
  • 153 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.